se ha leído el artículo
array:25 [ "pii" => "S0211699523001777" "issn" => "02116995" "doi" => "10.1016/j.nefro.2023.11.006" "estado" => "S300" "fechaPublicacion" => "2024-05-01" "aid" => "1226" "copyright" => "Sociedad Española de Nefrología" "copyrightAnyo" => "2023" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Nefrologia. 2024;44:455-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S2013251424001044" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2023.12.007" "estado" => "S300" "fechaPublicacion" => "2024-05-01" "aid" => "1228" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2024;44:456-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Response to the attached letter “IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2” by H. Daungsupawong and V. Wiwanitkit" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "456" "paginaFinal" => "457" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Contestación a la carta adjunta “IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2” de H. Daungsupawong and V. Wiwanitkit" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Leonardo Calle Garcia" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Leonardo" "apellidos" => "Calle Garcia" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0211699523001777" "doi" => "10.1016/j.nefro.2023.11.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699523001777?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251424001044?idApp=UINPBA000064" "url" => "/20132514/0000004400000003/v1_202407151105/S2013251424001044/v1_202407151105/en/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S0211699523001844" "issn" => "02116995" "doi" => "10.1016/j.nefro.2023.12.002" "estado" => "S300" "fechaPublicacion" => "2024-05-01" "aid" => "1228" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Nefrologia. 2024;44:456-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Response to the attached letter “IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2” by H. Daungsupawong and V. Wiwanitkit" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "456" "paginaFinal" => "457" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Contestación a la carta adjunta “IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2” de H. Daungsupawong and V. Wiwanitkit" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Leonardo Calle Garcia" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Leonardo" "apellidos" => "Calle Garcia" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699523001844?idApp=UINPBA000064" "url" => "/02116995/0000004400000003/v2_202410292048/S0211699523001844/v2_202410292048/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0211699524000080" "issn" => "02116995" "doi" => "10.1016/j.nefro.2024.02.002" "estado" => "S300" "fechaPublicacion" => "2024-05-01" "aid" => "1239" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Nefrologia. 2024;44:454-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Respuesta a la carta: «Preeclampsia: un importante factor de riesgo de enfermedad renal crónica frecuente y desafortunadamente olvidado»" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "454" "paginaFinal" => "455" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Response to the letter: «Preeclampsia: a relevant chronic kidney disease risk factor frequently and unfortunately forgotten»" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jose Luis Górriz, Rafael García Maset" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Jose Luis" "apellidos" => "Górriz" ] 1 => array:2 [ "nombre" => "Rafael" "apellidos" => "García Maset" ] 2 => array:1 [ "colaborador" => "en nombre de los autores del documento de información y consenso para la detección y manejo de la ERC" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2013251424001305" "doi" => "10.1016/j.nefroe.2024.02.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251424001305?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699524000080?idApp=UINPBA000064" "url" => "/02116995/0000004400000003/v2_202410292048/S0211699524000080/v2_202410292048/es/main.assets" ] "asociados" => array:1 [ 0 => array:18 [ "pii" => "S0211699523001844" "issn" => "02116995" "doi" => "10.1016/j.nefro.2023.12.002" "estado" => "S300" "fechaPublicacion" => "2024-05-01" "aid" => "1228" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Nefrologia. 2024;44:456-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Response to the attached letter “IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2” by H. Daungsupawong and V. Wiwanitkit" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "456" "paginaFinal" => "457" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Contestación a la carta adjunta “IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2” de H. Daungsupawong and V. Wiwanitkit" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Leonardo Calle Garcia" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Leonardo" "apellidos" => "Calle Garcia" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699523001844?idApp=UINPBA000064" "url" => "/02116995/0000004400000003/v2_202410292048/S0211699523001844/v2_202410292048/en/main.assets" ] ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2" "tieneTextoCompleto" => true "saludo" => "<span class="elsevierStyleItalic">Dear Editor,</span>" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "455" "paginaFinal" => "456" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Hinpetch Daungsupawong, Viroj Wiwanitkit" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Hinpetch" "apellidos" => "Daungsupawong" "email" => array:1 [ 0 => "hinpetchdaung@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Viroj" "apellidos" => "Wiwanitkit" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Private Academic Consultant, Phonhong, Lao Democratic People's Republic" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Adjunct Professor, Chandigarh University, India" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Nefropatía por IgA y hematuria después de recibir la vacuna para SARS-CoV-2" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We would like to comment on the publication “Hematuria in patients with IgA nephropathy after vaccine for SARS-CoV-2.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a>” The study looks at three examples of IgA nephropathy patients who acquired macroscopic hematuria after receiving the COVID-19 vaccination. It emphasizes that this side effect has been linked to the use of mRNA vaccines (Moderna®, Pfizer®) and viral vector vaccines (AstraZeneca®). The patients in the cases were asymptomatic, and the hematuria went away on its own after 24–72<span class="elsevierStyleHsp" style=""></span>h. Given the increased mortality risk from COVID-19, the findings suggests that finishing immunization in these susceptible patients is justified.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The article only includes three cases, which is a tiny sample size and may not be representative of the general community. The lack of data on the prevalence of hematuria after COVID-19 immunization in individuals with IgA nephropathy makes determining the importance of this side event challenging. The research does not include previous studies or literature on the relationship between immunizations and renal problems in IgA nephropathy patients, limiting the context for the findings. The article does not state if other potential causes of hematuria, such as urinary tract infections or renal stones, were explored. These could be confounding factors. The primary concern for any negative reaction to COVID-19 immunization is the confounding effects of underlying disease, as well as the possibility of previously undiagnosed silent COVID-19 infection, which could disrupt the normal immunological response to vaccine.</p><p id="par0015" class="elsevierStylePara elsevierViewall">If this is a true case of vaccination-induced hematuria, the possible mechanism for vaccine-induced hematuria is intriguing. One theory is that the COVID-19 vaccine activates CD4 and CD8 T cells, resulting in a systemic cytokine cascade. This cascade may increase IgA1 production, resulting in macroscopic hematuria in patients with IgA nephropathy. Another possibility is that the vaccine-induced immune response causes inflammation and immune complex deposition in the glomeruli, leading to blood vessel damage and hematuria. This mechanism is similar to how IgA nephropathy develops, in which immune complexes deposit in the glomeruli and cause inflammation.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Data availability statement</span><p id="par0020" class="elsevierStylePara elsevierViewall">There is no new data generated.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Authors’ contribution</span><p id="par0025" class="elsevierStylePara elsevierViewall">H.D., 50% ideas, writing, analyzing, and approval. V.W., 50% ideas, supervision, and approval.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflict of interest</span><p id="par0030" class="elsevierStylePara elsevierViewall">None.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Data availability statement" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Authors’ contribution" ] 2 => array:2 [ "identificador" => "sec0015" "titulo" => "Conflict of interest" ] 3 => array:2 [ "identificador" => "xack784692" "titulo" => "Acknowledgement" ] 4 => array:1 [ "titulo" => "Reference" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Reference" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:1 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hematuria in patients with IgA nephropathy after vaccine for SARS-CoV-2" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Calle Garcia" 1 => "C. Martin Varas" 2 => "G. Urzola Rodriguez" 3 => "M. Marcos Hidalgo" 4 => "A. Rodriguez Gomez" 5 => "A. Molina Ordas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Nefrologia (Engl Ed)" "fecha" => "2023" "volumen" => "43" "paginaInicial" => "657" "paginaFinal" => "659" ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack784692" "titulo" => "Acknowledgement" "texto" => "<p id="par0035" class="elsevierStylePara elsevierViewall">None.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/02116995/0000004400000003/v2_202410292048/S0211699523001777/v2_202410292048/en/main.assets" "Apartado" => array:4 [ "identificador" => "48186" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Cartas al Director" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/02116995/0000004400000003/v2_202410292048/S0211699523001777/v2_202410292048/en/main.pdf?idApp=UINPBA000064&text.app=https://www.revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699523001777?idApp=UINPBA000064" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 6 | 2 | 8 |
2024 Octubre | 103 | 58 | 161 |
2024 Septiembre | 91 | 39 | 130 |
2024 Agosto | 134 | 77 | 211 |
2024 Julio | 119 | 44 | 163 |
2024 Junio | 155 | 66 | 221 |
2024 Mayo | 656 | 84 | 740 |
2024 Abril | 127 | 36 | 163 |
2024 Marzo | 194 | 42 | 236 |
2024 Febrero | 345 | 58 | 403 |
2024 Enero | 1937 | 52 | 1989 |
2023 Diciembre | 214 | 96 | 310 |